Abraxis Bioscience Inc. New (ABII)
Symbol Info
Listed Symbol ABII
Name Abraxis Bioscience Inc. New
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2009-12-01
Latest Fiscal Revenue $359,050,000
Latest Fiscal EPS $-2.57
Price Info
21 Day Moving Average $77.3895
21 Day EMA $77.373110
50 Day Moving Average $75.8290
50 Day EMA $75.581890
200 Day EMA $66.643860
200 Day Moving Average 58.308060
52 Week High $78.62
52 Week Low $31.20
52 Week Change $120.546810
Alpha 0.026177
Beta 0.3927
Standard Deviation 0.199530
R2 0.015788
Periods 35
Share Information
10 Day Average Volume 87,136
20 Day Average Volume 77,625
30 Day Average Volume 71,468
50 Day Average Volume 75,567
Outstanding Shares 40,465,643
Float Shares 40,465,643
Percent Float 100.00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 113
Institute Holdings Date 2010-09-01
Institute Bought Previous 3 Months 1,735,032
Institute Holdings Percent 15.400000
Institute Sold Previous 3 Months 1,663,498
Insider Holdings Date 2010-09-01
Insider Bought Previous 3 Months -
Insider Holdings Percent 1.30%
Insider Sold Previous 3 Months -
Insiders Shares Owned -
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $1.2500000
21 Day Percent Change 1.62%
30 Day Price Change $2.3300018
30 Day Percent Change 3.07%
Month To Date Price Change $0.9100
Month To Date Percent 1.18%
90 Day Price Change $3.650002
90 Day Percent Change 4.89%
Quarter To Date $0.910004
Quarter To Date Percent 1.18%
180 Day Price Change $27.340000
180 Day Percent Change 53.70%
200 Day Price Change $26.619999
200 Day Percent Change 51.56%
Year To Date $37.700000
Year To Date Percent 92.97%
Profile
Description
Details
Issue Type CS
Market Cap $3,166,436,565
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding -
CEO Bruce J. Wendel
Employees 885
Last Audit UQ
Classification
CIK 0001409012
Industry
Sector
NAICS 541711
Info
Address 11755 Wilshire Boulevard
Suite 2000
Los Angeles, CA 90025
Website www.abraxisbio.com
Facisimile (310) 998-8553
Telephone (310) 883-1300
Email investorrelations@abraxisbio.com
Key Ratios
Profitability
EBIT Margin -18.6
EBITDA Margin -3.7
Pre-Tax Profit Margin -
Profit Margin Cont -16.9
Gross Margin 79.10
Profit Margin TOT -16.9
Income Statements
Revenue $447,464,000
Revenue Per Share $11.0579
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $-
Price To Sales 7.076406
Price To Free Cash -51.4
PE High Last 5 Years -
Price To Book 3.8
Price To Cash Flow -196.5
PE Low Last 5 Years -
Price To Tangible Book 6.9
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 2.1
Leverage Ratio 1.3
Quick Ratio 1.4
Long Term Debt To Capital -
Assets
Receivables Turnover 8.8
Invoice Turnover 1.60
Assets Turnover 0.40
Management Effectiveness
Return Assets -7.1
Return On Equity -
Return On Capital -9
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
ABII
Abraxis Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.